The makers of the stem cell therapy, Geron Corporation, estimated that it would take several months for the stem cells to replicate and for the GRNOPC1 therapy to be evaluated for success or failure.
줄기세포 치료의 창시자 Geron Corporation은 줄기세포가 복제되고 GRNOPC1치료가 성공 또는 실패 여부를 평가하는데 수개월이 걸릴 것으로 추정했다.